Surveillance of omadacycline against 35,000 bacterial clinical isolates from the United States (2019-2023).
- DOI
- 10.1016/j.diagmicrobio.2025.116711
- Published
- 2025 Mar
- Container
- Diagnostic microbiology and infectious disease
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.diagmicrobio.2025.116711,
title = {Surveillance of omadacycline against 35,000 bacterial clinical isolates from the United States (2019-2023).},
author = {Huband MD and Fedler KA and Mendes RE and Sader HS and Anastasiou D and Serio AW and Castanheira M},
year = {2025},
journal = {Diagnostic microbiology and infectious disease},
doi = {10.1016/j.diagmicrobio.2025.116711},
url = {https://doi.org/10.1016/j.diagmicrobio.2025.116711}
}RIS
TY - JOUR TI - Surveillance of omadacycline against 35,000 bacterial clinical isolates from the United States (2019-2023). AU - Huband MD AU - Fedler KA AU - Mendes RE AU - Sader HS AU - Anastasiou D AU - Serio AW AU - Castanheira M PY - 2025 JO - Diagnostic microbiology and infectious disease DO - 10.1016/j.diagmicrobio.2025.116711 UR - https://doi.org/10.1016/j.diagmicrobio.2025.116711 ER -
APA
MD, H., KA, F., RE, M., HS, S., D, A., AW, S., & M, C. (2025). Surveillance of omadacycline against 35,000 bacterial clinical isolates from the United States (2019-2023).. Diagnostic microbiology and infectious disease. https://doi.org/10.1016/j.diagmicrobio.2025.116711
Source records
- pubmed · retrieved 2026-09-26T22:10:56.806Z